Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characteristics of Recurrent Hepatocellular Carcinoma Based on Serum AFP, PIVKA-II, and Genetic Mutations.

Medicina (Kaunas, Lithuania) - 10 Mar 2026

Cho In Soo, Ahn Keun Soo, Jeong Sangkyun, Kim Tae-Seok, Kim Min Jae, Yang Seung Kyoung, Cho Sunwha, Kim Yong Hoon

Abstract excerpt

Background and Objectives: Reliable tools for evaluating tumor biology and forecasting clinical outcomes in recurrent hepatocellular carcinoma (HCC) remain scarce, and molecular characterization through genetic profiling is equally limited in this setting. This investigation explores whether serum tumor marker expression patterns correlate with genomic mutation profiles, and whether such correlations may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Hepatocellular

Share to Liver Neoplasms

Share to Neoplasm Recurrence, Local

Share to Protein Precursors

Share to Prothrombin

Source

Open in PubMed Open full text

Identifiers

PMID: 41901589
DOI: 10.3390/medicina62030508
PMCID: PMC13028399

Genes

AFP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characteristics of Recurrent Hepatocellular Carcinoma Based on Serum AFP, PIVKA-II, and Genetic Mutations.PMID 41901589Read ↗

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular CarcinomasSemantic proximity Read ↗

Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.Semantic proximity Read ↗

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.Semantic proximity Read ↗

Functional Interpretation of Recurrent Genetic Variants in Hepatocellular Carcinoma: Molecular Consequences and Clinical Relevance.Semantic proximity Read ↗

Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrencesSemantic proximity Read ↗

Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective Analysis.Semantic proximity Read ↗

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancerSemantic proximity Read ↗

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.Semantic proximity Read ↗

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrenceSemantic proximity Read ↗

Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort StudySemantic proximity Read ↗

Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases.Semantic proximity Read ↗

Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.